Author:
Haynes D. R.,Hutchens M. J.,Whitehouse M. W.,Vernon-Roberts B.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Immunology
Reference21 articles.
1. Conaghan PG, Brooks P. Disease modifying anti-rheumatic drugs, including methotrexate, sulfasalazine, gold, antimalarials, and d-penicillamine. Curr Opin Rheumatol. 1993;5:276–81.
2. Sany J. Immunological treatment of rheumatoid arthritis. Clin Exp Rheumatol. 1990;8(5):81–8.
3. Larsson P, Holmdahl R, Denker L, Klareskog L. In vivo treatment with W3/13 (anti-pan T) but not with OX8 (anti-suppressor/cytotoxic T) monoclonal antibodies impedes the development of adjuvant arthritis in rats. Immunology. 1985;56:383–91.
4. Whitehouse DJ, Whitehouse MW, Pearson CM. Passive transfer of adjuvant-induced arthritis and allergic encephalomyelitis in rats using thoracic duct lymphocytes. Nature. 1969;224:1322–3.
5. Cohen IR, Holoshitz J, Van Eden W, Frenkel A. T lymphocyte clones illuminate pathogenesis and affect therapy of experimental arthritis. Arthritis Rheum. 1985;28:841–5.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Professor Barrie Vernon-Roberts, AO, MD, BSc, PhD, FRCPath, FRCPA, FAOrthA (Hon), FRS.SA;Inflammopharmacology;2013-07-04
2. Tenidap, an agonist of the inwardly rectifying K+channel Kir2·3, delays the onset of cortical epileptiform activity in a model of chronic temporal lobe epilepsy;Neurological Research;2013-07